Apathy: Neurobiology, Assessment and Treatment

키워드

참고문헌 (56)

1. Marin RS, "Apathy : a neuropsychiatric syndrome", J Neuropsychiatry Clin Neurosci, 3, pp.243~254 (1991)
2. Robert P, "Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group", Eur Psychiatry, 54, pp.71~76 (2018)
3. Chong TT, "The role of dopamine in the pathophysiology and treatment of apathy", Prog Brain Res, 229, pp.389~426 (2016)
4. van Reekum R, "Apathy: why care?", J Neuropsychiatry Clin Neurosci, 17, pp.7~19 (2005)
5. Husain M, "Neuroscience of apathy and anhedonia : a transdiagnostic approach", Nat Rev Neurosci, 19, pp.470~484 (2018)
6. van der Linde RM, "Patterns and persistence of behavioural and psychological symptoms in those with cognitive impairment : the importance of apathy", Int J Geriatr Psychiatry, 32, pp.306~315 (2017)
7. Massimo L, "Differentiating subtypes of apathy to improve person-centered care in frontotemporal degeneration", J Gerontol Nurs, 40, pp.58~65 (2014)
8. Pardini M, "Prevalence and cognitive underpinnings of isolated apathy in young healthy subjects", J Affect Disord, 189, pp.272~275 (2016)
9. Brodaty H, "Do people become more apathetic as they grow older? A longitudinal study in healthy individuals", Int Psychogeriatr, 22, pp.426~436 (2010)
10. Nobis L, "Apathy in Alzheimer’s disease", Curr Opin Behav Sci, 22, pp.7~13 (2018)
11. Radakovic R, "Multidimensional apathy : evidence from neurodegenerative disease", Curr Opin Behav Sci, 22, pp.42~49 (2018)
12. Rizvi SJ, "Assessing anhedonia in depression : potentials and pitfalls", Neurosci Biobehav Rev, 65, pp.21~35 (2016)
13. Kano M, "The alexithymic brain : the neural pathways linking alexithymia to physical disorders", Biopsychosoc Med, 7, pp.1~ (2013)
14. Le Heron C, "The anatomy of apathy : a neurocognitive framework for amotivated behaviour", Neuropsychologia, 118(Pt B), pp.54~67 (2018)
15. Huey ED, "Brain regions brain regions involved in arousal and reward processing are associated with apathy in Alzheimer’s disease and frontotemporal dementia", J Alzheimers Dis, 55, pp.551~558 (2017)
16. Gard DE, "Anhedonia in schizophrenia : distinctions between anticipatory and consummatory pleasure", Schizophr Res, 93, pp.253~260 (2007)
17. Kringelbach ML, "The human orbitofrontal cortex : linking reward to hedonic experience", Nat Rev Neurosci, 6, pp.691~702 (2005)
18. Berns GS, "Predictability modulates human brain response to reward", J Neurosci, 21, pp.2793~2798 (2001)
19. Simon JJ, "Neural correlates of reward processing in schizo-phrenia--relationship to apathy and depression", Schizophr Res, 118, pp.154~161 (2010)
20. Steffens DC, "Structural neuroimaging and mood disorders : recent findings, implications for classification, and future directions", Biol Psychiatry, 43, pp.705~712 (1998)
21. Alexopoulos GS, "Frontostriatal and limbic dysfunction in late-life depression", Am J Geriatr Psychiatry, 10, pp.687~695 (2002)
22. Cieri F, "Late-life depression : modifications of brain resting state activity", J Geriatr Psychiatry Neurol, 30, pp.140~150 (2017)
23. Tadayonnejad R, "Multimodal brain connectivity analysis in unmedicated late-life depression", PLoS One, 9, pp.e96033~ (2014)
24. Aizenstein HJ, "Altered functioning of the executive control circuit in late-life depression : episodic and persistent phenomena", Am J Geriatr Psychiatry, 17, pp.30~42 (2009)
25. Brassen S, "Ventromedial prefrontal cortex processing during emotional evaluation in late-life depression : a longitudinal functional magnetic resonance imaging study", Biol Psychiatry, 64, pp.349~355 (2008)
26. Starkstein SE, "Apathy following cerebrovascular lesions", Stroke, 24, pp.1625~1630 (1993)
27. Tay J, "Network neuroscience of apathy in cerebrovascular disease", Prog Neurobiol, 188, pp.101785~ (2020)
28. Jang SH, "Injury of the prefronto-caudate tract in a patient with apathy following intracerebral hemorrhage in the caudate nucleus", Acta Neurol Belg, 119, pp.143~145 (2019)
29. Hollocks MJ, "Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes", Brain, 138(Pt 12), pp.3803~3815 (2015)
30. Tuladhar AM, "Structural network changes in cerebral small vessel disease", J Neurol Neurosurg Psychiatry, 91, pp.196~203 (2020)
31. Padala PR, "Repetitive transcranial magnetic stimulation for apathy in mild cognitive impairment : a double-blind, randomized, sham-controlled, cross-over pilot study", Psychiatry Res, 261, pp.312~318 (2018)
32. Lyketsos CG, "Mental and behavioral disturbances in dementia : findings from the Cache County Study on Memory in Aging", Am J Psychiatry, 157, pp.708~714 (2000)
33. Kim JW, "Microstructural alteration of the anterior cingulum is associated with apathy in Alzheimer disease", Am J Geriatr Psychiatry, 19, pp.644~653 (2011)
34. Mendez MF, "An evidencebased review of the psychopathology of frontotemporal dementia : a report of the ANPA Committee on Research", J Neuropsychiatry Clin Neurosci, 20, pp.130~149 (2008)
35. Rosen HJ, "Neuroanatomical correlates of behavioural disorders in dementia", Brain, 128(Pt 11), pp.2612~2625 (2005)
36. Sarazin M, "Metabolic correlates of behavioral and affective disturbances in frontal lobe pathologies", J Neurol, 250, pp.827~833 (2003)
37. Liu J, "Pharmacological treatment of apathy in Lewy body disorders : a systematic review", Parkinsonism Relat Disord, 60, pp.14~24 (2019)
38. Pagonabarraga J, "Apathy in Parkinson’s disease : clinical features, neural substrates, diagnosis, and treatment", Lancet Neurol, 14, pp.518~531 (2015)
39. Radakovic R, "Developing a new apathy measurement scale : Dimensional Apathy Scale", Psychiatry Res, 219, pp.658~663 (2014)
40. Sockeel P, "The Lille apathy rating scale(LARS), a new instrument for detecting and quantifying apathy : validation in Parkinson’s disease", J Neurol Neurosurg Psychiatry, 77, pp.579~584 (2006)
41. Ang YS, "Distinct subtypes of apathy revealed by the apathy motivation index", PLoS One, 12, pp.e0169938~ (2017)
42. Theleritis C, "A review of neuroimaging findings of apathy in Alzheimer’s disease", Int Psychogeriatr, 26, pp.195~207 (2014)
43. Theleritis C, "A systematic review of non-pharmacological treatments for apathy in dementia", Int J Geriatr Psychiatry, 33, pp.e177~ (2018)
44. Yuen GS, "Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response", J Affect Disord, 166, pp.179~186 (2014)
45. Moretti R, "Rivastigmine in subcortical vascular dementia : an open 22-month study", J Neurol Sci, 203-204, pp.141~146 (2002)
46. Rea R, "Apathy in Alzheimer’s disease: any effective treatment?", ScientificWorldJournal, 2014, pp.421385~ (2014)
47. Rea R, "Apathy treatment in Alzheimer’s disease : interim results of the ASCOMALVA trial", J Alzheimers Dis, 48, pp.377~383 (2015)
48. Padala PR, "Methylphenidate for apathy in community-dwell-ing older veterans with mild Alzheimer’s disease : a doubleblind, randomized, placebo-controlled trial", Am J Psychiatry, 175, pp.159~168 (2018)
49. Takemoto M, "The efficacy of sertraline, escitalopram, and nicergoline in the treatment of depression and apathy in Alzheimer’s disease : the Okayama Depression and Apathy Project(ODAP)", J Alzheimers Dis, 76, pp.769~772 (2020)
50. Pérez-Pérez J, "Head-to-head comparison of the neuropsychiatric effect of dopamine agonists in Parkinson’s disease : a prospective, cross-sectional study in non-demented patients", Drugs Aging, 32, pp.401~407 (2015)
51. Overvliet GM, "Pharmacological treatment of apathy in Parkinson’s disease, review of the literature", Parkinsonism Relat Disord, 79(Suppl 1), pp.E70~E71 (2020)
52. Moretti R, "Rivastigmine as a symptomatic treatment for apathy in Parkinson’s dementia complex : new aspects for this riddle", Parkinsons Dis, 2017, pp.6219851~ (2017)
53. Zahodne LB, "Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson’s disease?", J Neuropsychiatry Clin Neurosci, 24, pp.326~330 (2012)
54. Callegari I, "Agomelatine improves apathy in frontotemporal dementia", Neurodegener Dis, 16, pp.352~356 (2016)
55. Herrmann N, "Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia", Am J Geriatr Psychiatry, 20, pp.789~797 (2012)
56. Finger E, "Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease : a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia(FOXY)", Alzheimers Res Ther, 10, pp.102~ (2018)

관련 논문AI추천